September 16, 2025 |

Lucid Group announces the evolution of its consulting division, Lucid Strategy Consulting, setting a new standard for deep-domain, knowledge-led consulting solutions for life sciences. We have brought together two Lucid divisions spanning management consulting and pharma asset strategy, to create an integrated consulting offering, enhancing the ability to support clients at critical moments of inflection. The division will be led by Simon Bates, whose extensive expertise in Strategy, Innovation, and Transformation across life sciences further strengthens our capability and commitment to support our clients in the life sciences and healthcare industries.
We solve complex, multifaceted problems for our clients. By achieving strategic clarity and pragmatic cross-functional alignment, our newly unified team helps to accelerate asset development and commercialisation, and drive operational effectiveness across client functions. The consulting we deliver is outcomes-driven. Ultimately, clients value Lucid Strategy Consulting for helping them optimise performance for their patients, customers, staff, and shareholders.
Creating Value for Clients
“Lucid Strategy Consulting brings together the right minds – strategic, scientific, commercial, and behavioural – to help our clients unlock progress,” said Simon Bates, Managing Director. “Patients’ evolving needs and behaviours, plus the complex challenges faced by healthcare providers and payors, mean life science clients need agility, innovation, and grit from their consulting partners. So we embed ourselves in our clients’ challenges, co-create pragmatic strategies that move people, align organisations and accelerate change where it matters most.”
Expanding Capabilities
“With expanded capabilities in asset and portfolio strategy, we empower clients to define clear ambitions, optimise investment behind their assets and indications, and maximise impact across the product lifecycle,” said Clare Reynolds, Senior Vice President. “Recent examples of impact include transforming strategic planning through AI-driven insights, using data and technology to elucidate a new patient pathway in a rare disease, and enabling faster market access and uptake for breakthrough therapies.”
Redefining Life Sciences Consulting
Lucid Strategy Consulting combines deep life sciences fluency, real-world insight, and “commercial/operational nous” to deliver clarity at moments of strategic uncertainty. The team, which brings global and key market expertise with offices in the US, UK, and India, combines scientific and commercial proficiency, with every consultant holding advanced degrees in life sciences, business management, or economics.
“Clients value our team’s deep scientific knowledge across multiple therapy areas, our strategic mindset, and our ability to tackle complex challenges through structured, data-driven problem-solving,” shared Dr Tavia Chetty, Manager. “I enjoy helping our clients to achieve their goals by conducting rigorous analyses, designing and implementing tailored, creative solutions that drive measurable impact.”
Our team, which is actively hiring to meet client demand, is seeking diverse talent and expertise to strengthen our ability to deliver transformative solutions across life sciences.
Want to find out how Lucid Strategy Consulting can support your next strategic challenge?
To accelerate impact and unlock potential for your assets and organisation, visit https://wearelucidgroup.com/our-capabilities/strategy-consulting
Connect with us on LinkedIn at www.linkedin.com/company/lucid-strategy-consulting
This content was provided by Lucid Group Communications Limited
Company Details
Latest Content from Lucid Group Communications Limited
Lucid bolsters their client services and facilities teams and spread their magic across the globe with new hires. Cindy Miller joins the Lighthouse team as an Account Director in the...
Lucid held their annual Summer Meeting last week. The event is all about taking the time out to celebrate colleagues, teams, and all they have achieved in the year so...
Last week’s Thirsty Thursday was all about data visualisation and was hosted by Katherine Mantell, Managing Director of Leading Edge – part of the Lucid family of companies.Katherine started the session with...
In a recent edition of PME, Dennis O’Brien, Lucid CEO and co-founder, discusses the potential of mobile health in improving patient outcomes – a goal that is at the heart...
Lucid’s pioneering and patient-centric approach to strategic medical communications was recognised yesterday as they scooped a total of four awards. These included: Excellence in Communications via Meetings for OptiMiSe –...
Last week, Lucid launched its first Thirsty Thursday session, during which everyone gets an opportunity to quench their thirst for knowledge and learn about new industry trends and techniques. Last...
In this month’s PME, Lucid CEO and co-founder, Dennis O’Brien, and Managing Director, Louise Verrall, discuss ‘Patient outcomes in practice: delivering value that transforms lives’. In response to the increasing...
Lucid Group are spreading their magic to the North West with three new hires, bolstering their client services and delivery teams. Helen Hutton is appointed as Business Unit Director for...
Lucid joined in on the royal wedding fervour today by celebrating the impending nuptials with a Royal Bake-off, producing cakes fit for the Queen and the new Princess. Lucid love...
